Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

Patients with triple-negative breast cancer (TNBC) — defined by lack of estrogen receptor and progesterone receptor expression as well as lack of human epidermal growth factor receptor 2 (HER2) amplification — have a poor prognosis. There is a need for targeted therapies to treat this condition. TNB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ma, Cynthia X., Cai, Shirong, Li, Shunqiang, Ryan, Christine E., Guo, Zhanfang, Schaiff, W. Timothy, Lin, Li, Hoog, Jeremy, Goiffon, Reece J., Prat, Aleix, Aft, Rebecca L., Ellis, Matthew J., Piwnica-Worms, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3314455/
https://ncbi.nlm.nih.gov/pubmed/22446188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI58765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados